KLF4 |
CGR8 (embryonic stem cells) |
KLF4 overexpression |
Permissive
Robust
|
Mus musculus |
GSE49848
...
|
MA0039.4
|
KLF4 |
mixture of cell types |
KLF4 KO |
Permissive
|
Mus musculus |
GSE65812
...
|
MA0039.4
|
KLF4 |
ES-E14 (E14, embryonic stem cells) |
MBD3 KO |
Permissive
|
Mus musculus |
GSE68400
...
|
MA0039.4
|
KLF4 |
B-cells |
Cebpa18h |
Permissive
|
Mus musculus |
GSE71215
...
|
MA0039.4
|
KLF4 |
B-cells |
Cebpa18h, OSKM1d |
Permissive
|
Mus musculus |
GSE71215
...
|
MA0039.4
|
KLF4 |
B-cells |
Cebpa18h, OSKM2d |
Permissive
|
Mus musculus |
GSE71215
...
|
MA0039.4
|
KLF4 |
E3.5 embryonic stem cells |
asynchronous cell cycle |
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
E3.5 embryonic stem cells |
asynchronous cell cycle |
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
E3.5 embryonic stem cells |
asynchronous cell cycle |
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
U87 (glioblastoma) |
R458A mutation |
Permissive
|
Homo sapiens |
GSE97632
...
|
MA0039.4
|
KLF4 |
WA09 (embryonic stem cells) |
Treatment: under normal conditions |
Permissive
Robust
|
Homo sapiens |
GSE105028
...
|
MA0039.4
|
KLF4 |
WA09 (embryonic stem cells) |
Treatment: under heat shock conditions |
Permissive
Robust
|
Homo sapiens |
GSE105028
...
|
MA0039.4
|
KLF4 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2 and Klf4 addition for 5 days Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0039.4
|
KLF4 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator) and Klf4 addition for 5 days Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0039.4
|
KLF4 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2, Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0039.4
|
KLF4 |
MRC-5 (fetal lung fibroblasts) |
Treatment: Oct4, Sox2-VP16 (strong activator), Klf4 and Myc addition for 5 days Passage: 8 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0039.4
|
KLF4 |
iPS (derived pancreatic precursor cells) |
Treatment: iPS protocol 3s2 Passage: 20 |
Permissive
|
Homo sapiens |
GSE81899
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
Robust
|
Mus musculus |
GSE99009
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shCtrl Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
Robust
|
Mus musculus |
GSE99009
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
Robust
|
Mus musculus |
GSE99009
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts |
Cell type: MEF expressing OKSM for 4 days Treatment: shRNA Genotype: shUbc9 Passage: 1 Source: mouse embryonic fibroblast cells E13.5 |
Permissive
Robust
|
Mus musculus |
GSE99009
...
|
MA0039.4
|
KLF4 |
Akt (5MOI, mouse prostate stem cell line) |
Passage: 11 |
Permissive
Robust
|
Mus musculus |
GSE114772
...
|
MA0039.4
|
KLF4 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: none; |
Permissive
|
Homo sapiens |
GSE41561
...
|
MA0039.4
|
KLF4 |
squamous cell carcinoma |
Conditions: low calcium (50uM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0039.4
|
KLF4 |
squamous cell carcinoma |
Conditions: high calcium (1.5mM) conditions for 24 hrs; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0039.4
|
KLF4 |
squamous cell carcinoma |
Treatment: 15,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0039.4
|
KLF4 |
squamous cell carcinoma |
Treatment: 5,000 cells were injected intradermally to form tumor allografts; Strain: C57BL/6; Tissue: skin; |
Permissive
|
Mus musculus |
GSE104142
...
|
MA0039.4
|
KLF4 |
E14TG2A (embryonic stem cells) |
Conditions: cultured in 2i medium for 3 days; |
Permissive
Robust
|
Mus musculus |
GSE92407
...
|
MA0039.4
|
KLF4 |
E14TG2A (embryonic stem cells) |
Conditions: cultured in serum medium; |
Permissive
Robust
|
Mus musculus |
GSE92407
...
|
MA0039.4
|
KLF4 |
BJ (fibroblasts) |
INDUCED |
Permissive
Robust
|
Homo sapiens |
GSE36570
|
MA0039.4
|
KLF4 |
keratinocytes |
diff |
Permissive
Robust
|
Homo sapiens |
GSE57702
|
MA0039.4
|
KLF4 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR265WJC
|
MA0039.4
|
KLF4 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE11431
...
|
MA0039.4
|
KLF4 |
mammary epithelial cells |
|
Permissive
|
Mus musculus |
GSE49445
...
|
MA0039.4
|
KLF4 |
J1 (embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE49137
...
|
MA0039.4
|
KLF4 |
J1 (embryonic stem cells) |
|
Permissive
|
Mus musculus |
GSE49137
...
|
MA0039.4
|
KLF4 |
CGR8 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE49848
...
|
MA0039.4
|
KLF4 |
3T3-L1 (embryonic fibroblasts) |
|
Permissive
Robust
|
Mus musculus |
GSE56872
...
|
MA0039.4
|
KLF4 |
mixture of cell types |
|
Permissive
|
Mus musculus |
GSE65812
...
|
MA0039.4
|
KLF4 |
B-cells |
|
Permissive
|
Mus musculus |
GSE71215
...
|
MA0039.4
|
KLF4 |
CD4+ CD8+ thymocytes |
|
Permissive
|
Mus musculus |
GSE76473
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing OSKM for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Klf4 from inducible system for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Oct4,Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Sox2,Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Oct4,Sox2 from pMX vector for 48h |
|
Permissive
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing Oct4,Sox2,Klf4 from pMX vector for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing OSKM and Flag-Fra1 for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
embryonic fibroblasts expressing OSKM and Esrrb for 48h |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
pre-induced pluripotent stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE90893
...
|
MA0039.4
|
KLF4 |
E3.5 embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
embryonic stem and neural progenitor cells |
|
Permissive
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
E3.5 embryonic stem cells |
|
Permissive
Robust
|
Mus musculus |
GSE92846
...
|
MA0039.4
|
KLF4 |
U87 (glioblastoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE97632
...
|
MA0039.4
|
KLF4 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE41561
|
MA0039.4
|
KLF4 |
hiPSC |
|
Permissive
Robust
|
Homo sapiens |
GSE56567
|
MA0039.4
|
KLF4 |
|
|
Permissive
|
Homo sapiens |
GSE64557
|
MA0039.4
|